- Home
- VIR vs CNNE Comparison
VIR vs CNNE Comparison
Compare VIR & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- CNNE
- Stock Information
- Founded
- VIR 2016
- CNNE 2014
- Country
- VIR United States
- CNNE United States
- Employees
- VIR N/A
- CNNE N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- CNNE Restaurants
- Sector
- VIR Health Care
- CNNE Consumer Discretionary
- Exchange
- VIR Nasdaq
- CNNE Nasdaq
- Market Cap
- VIR 1.4B
- CNNE 1.1B
- IPO Year
- VIR 2019
- CNNE N/A
- Fundamental
- Price
- VIR $6.93
- CNNE $18.75
- Analyst Decision
- VIR Buy
- CNNE Buy
- Analyst Count
- VIR 6
- CNNE 2
- Target Price
- VIR $35.67
- CNNE $22.50
- AVG Volume (30 Days)
- VIR 1.2M
- CNNE 793.5K
- Earning Date
- VIR 05-01-2025
- CNNE 05-08-2025
- Dividend Yield
- VIR N/A
- CNNE 2.84%
- EPS Growth
- VIR N/A
- CNNE N/A
- EPS
- VIR N/A
- CNNE N/A
- Revenue
- VIR $74,205,000.00
- CNNE $452,500,000.00
- Revenue This Year
- VIR N/A
- CNNE N/A
- Revenue Next Year
- VIR $17.69
- CNNE $2.01
- P/E Ratio
- VIR N/A
- CNNE N/A
- Revenue Growth
- VIR N/A
- CNNE N/A
- 52 Week Low
- VIR $6.56
- CNNE $15.99
- 52 Week High
- VIR $14.45
- CNNE $22.99
- Technical
- Relative Strength Index (RSI)
- VIR 30.40
- CNNE 57.07
- Support Level
- VIR $6.75
- CNNE $15.99
- Resistance Level
- VIR $7.26
- CNNE $19.15
- Average True Range (ATR)
- VIR 0.37
- CNNE 0.62
- MACD
- VIR -0.05
- CNNE 0.11
- Stochastic Oscillator
- VIR 11.73
- CNNE 87.34
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.